Cheplapharm Arzneimittel GmbH
(the “Issuer”)
Ziegelhof 24
17489 Greifswald
Germany
Satisfaction Notice of Redemption of
€500,000,000 3.500% Senior Secured Notes due 2027 of the Issuer (the “Notes”)
Reg S: ISIN: XS2112973107 / Common Code: 211297310
144A: ISIN: XS2112973362 / Common Code: 211297336
On June 19, 2025, the Issuer delivered a conditional notice of redemption (the “Notice of Conditional Full Redemption”) in full of its €500,000,000 3.500% Senior Secured Notes due 2027 (the “Notes”).
The Issuer confirms that the Financing Condition (as defined in the Notice of Conditional Full Redemption) has been satisfied on July 2, 2025. The redemption of the Notes will occur on July 3, 2025 (the “Redemption Date”). The total redemption amount for the Notes is €500,000,000. The redemption price of the Notes is 100.000% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest from (and including) February 15, 2025 (the last date upon which interest on the Notes was paid) to, but not including, the Redemption Date and Additional Amounts, if any (the “Redemption Price”), which comprises (i) the principal amount of the Notes to be redeemed of €500,000,000 and (ii) accrued but unpaid interest equal to €6,708,333.33.